7 results
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... • Weakness: Starts ... Diagnosis: • ... #diagnosis #management ... #treatment #neurology
NINDS Diagnostic Criteria for Guillain Barre Syndrome 
Features Required for Guillain-Barré Syndrome:
 • Progressive muscle weakness
Criteria for Guillain ... Features Required for Guillain-Barré ... , Mild sensory symptoms ... signs, Cranial nerve ... #neurology #neuropathy
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... than one after symptom ... #Barre #Syndrome ... #diagnosis #management ... #neurology
Statin Induced Muscle Toxicity - Summary

Clinical Presentation:
 • Elevations of serum creatine kinase with proximal myalgia
toxic myopathy, hypothyroid-induced ... myopathy, Guillain-Barré ... Atorvastatin Diagnosis ... toxicity #myopathy #diagnosis ... #management #treatment
Median Nerve Tension Test (Upper-Limb Neurodynamic Tests, ULNT1)

To assess for Median Nerve Peripheral Neuropathy

Shoulder abduction →
positive with symptom ... ULTT1 #clinical #video ... #physicalexam #sports ... #msk #orthopedics ... #neurology #ULNT
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
compression of nerve ... spine L1-L5 Symptoms ... Differential Diagnosis ... Tethered cord • Guillain-Barre ... #causes #neurology
Multiple Sclerosis - Summary

Multiple Sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system
• Or brainstem syndromes ... Multiple Sclerosis Diagnosis ... objective evidence of neurologic ... taper 3-7 days - Short ... #management #neurology